The Biostatistics Shared Resource provides collaborative statistical support to Fred Hutchinson/University of Washington Cancer Consortium (Consortium) members in any of the Consortium research programs. Such support may include any or all of the following: selection of primary and secondary endpoints, study design, sample size and power calculations, randomization procedures, design of data collection instruments, design of early stopping criteria, interim monitoring, data retrieval and analysis and manuscript preparation and review. The resource emphasizes the importance of establishing ongoing and continuing collaboration with biostatisticians during the entire research effort, rather than one-time consultation without appropriate context. Most of the funding for this collaborative effort comes from research grants and contracts. The CCSG supported effort ensures that a stable biostatistical staff is available to Consortium investigators, and in particular provides a resource to support projects that require only a small level of biostatistical support or support on an occasional basis, and to provide assistance to investigators developing new or continuing proposals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-39
Application #
8561931
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-01-01
Budget End
2013-12-31
Support Year
39
Fiscal Year
2013
Total Cost
$440,159
Indirect Cost
$167,897
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Gantt, Soren; Orem, Jackson; Krantz, Elizabeth M et al. (2016) Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants. J Infect Dis 214:36-44
Cheng, Guang-Shing; Campbell, Angela P; Xie, Hu et al. (2016) Correlation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 22:925-31
Rufener, Gregory A; Press, Oliver W; Olsen, Philip et al. (2016) Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab. Cancer Immunol Res 4:509-19
Yu, Jeffrey; Storer, Barry E; Kushekhar, Kushi et al. (2016) Biomarker Panel for Chronic Graft-Versus-Host Disease. J Clin Oncol 34:2583-90
Cohen, Stacey A; Laurino, Mercy; Bowen, Deborah J et al. (2016) Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice. Cancer 122:393-401
Mather, Cheryl A; Mooney, Sean D; Salipante, Stephen J et al. (2016) CADD score has limited clinical validity for the identification of pathogenic variants in noncoding regions in a hereditary cancer panel. Genet Med 18:1269-1275
Chen, Robert; Gopal, Ajay K; Smith, Scott E et al. (2016) Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma. Blood 128:1562-6
Martin, Paul J; Fan, Wenhong; Storer, Barry E et al. (2016) Replication of associations between genetic polymorphisms and chronic graft-versus-host disease. Blood 128:2450-2456
Song, Xiaoling; Schenk, Jeannette M; Diep, Pho et al. (2016) Measurement of Circulating Phospholipid Fatty Acids: Association between Relative Weight Percentage and Absolute Concentrations. J Am Coll Nutr 35:647-656
Santiago-Torres, Margarita; Kratz, Mario; Lampe, Johanna W et al. (2016) Metabolic responses to a traditional Mexican diet compared with a commonly consumed US diet in women of Mexican descent: a randomized crossover feeding trial. Am J Clin Nutr 103:366-74

Showing the most recent 10 out of 1027 publications